Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 172Breast Neoplasms 24Neoplasms 13Leiomyoma 11Polycystic Ovary Syndrome 5Prostate Adenocarcinoma 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Adenocarcinoma 3Salivary Gland Neoplasms 2Rare Diseases 2Myofibroma 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Breast Neoplasms, Male 2Uveal Melanoma 1Uterine Neoplasms 1Urogenital Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasm Duct 1Respiratory Tract Diseases 1Recurrence 1Puberty, Precocious 1

Interventions

Propranolol 8Timolol 5Prednisolone 4Prednisone 3Adrenergic beta-Antagonists 3Solutions 2Saline Solution 2Methylprednisolone 2Adrenal Cortex Hormones 2prednisolone phosphate 1Vincristine 1Tomography, Optical Coherence 1Steroids 1Sodium Chloride 1Sirolimus 1Population Groups 1Ointments 1Nadolol 1Mupirocin 1Leuprolide 1Lasers, Semiconductor 1Lasers, Dye 1Imiquimod 1Gels 1Everolimus 1Bleomycin 1Atenolol 1Acebutolol 168Ga-1,4,7-triazacyclononane-N,N',N''-triacetic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hemangioma × Leuprolide × Clear all
NCT00004436 2015-03-25

Randomized Study of Hormonal Regulation of Infantile Hemangioma

FDA Office of Orphan Products Development

Phase NA Completed
30 enrolled

Hemangioma, Respiratory Tract Diseases, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡